Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Deutsche Bank Aktiengesellschaft stock logo
DB
Deutsche Bank Aktiengesellschaft
$26.78
+1.4%
$23.53
$13.70
$26.96
$53.35B1.032.30 million shs3.23 million shs
Meta Platforms, Inc. stock logo
META
Meta Platforms
$597.02
+4.3%
$575.29
$442.65
$740.91
$1.45T1.2414.46 million shs24.70 million shs
Medicure Inc. stock logo
MPH
Medicure
C$0.83
-12.6%
C$0.80
C$0.63
C$1.26
C$8.66M0.95,083 shs1,500 shs
Voyageur Pharmaceuticals Ltd. stock logo
VM
Voyageur Pharmaceuticals
C$0.19
C$0.17
C$0.04
C$0.25
C$28.79M0.32212,835 shs50,750 shs
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Deutsche Bank Aktiengesellschaft stock logo
DB
Deutsche Bank Aktiengesellschaft
+1.27%+4.26%+10.02%+37.16%+65.62%
Meta Platforms, Inc. stock logo
META
Meta Platforms
+4.34%+9.09%+2.24%-13.37%+35.94%
Medicure Inc. stock logo
MPH
Medicure
0.00%0.00%+5.06%+1.22%-22.43%
Voyageur Pharmaceuticals Ltd. stock logo
VM
Voyageur Pharmaceuticals
0.00%+8.57%-5.00%+5.56%+280.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Deutsche Bank Aktiengesellschaft stock logo
DB
Deutsche Bank Aktiengesellschaft
2.6107 of 5 stars
0.03.03.30.02.00.02.5
Meta Platforms, Inc. stock logo
META
Meta Platforms
4.071 of 5 stars
3.53.01.70.03.23.31.9
Medicure Inc. stock logo
MPH
Medicure
N/AN/AN/AN/AN/AN/AN/AN/A
Voyageur Pharmaceuticals Ltd. stock logo
VM
Voyageur Pharmaceuticals
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Deutsche Bank Aktiengesellschaft stock logo
DB
Deutsche Bank Aktiengesellschaft
2.83
Moderate BuyN/AN/A
Meta Platforms, Inc. stock logo
META
Meta Platforms
2.91
Moderate Buy$696.4516.65% Upside
Medicure Inc. stock logo
MPH
Medicure
0.00
N/AN/AN/A
Voyageur Pharmaceuticals Ltd. stock logo
VM
Voyageur Pharmaceuticals
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest MPH, META, DB, and VM Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/1/2025
Meta Platforms, Inc. stock logo
META
Meta Platforms
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$740.00 ➝ $740.00
5/1/2025
Meta Platforms, Inc. stock logo
META
Meta Platforms
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$624.00 ➝ $676.00
5/1/2025
Meta Platforms, Inc. stock logo
META
Meta Platforms
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$705.00 ➝ $640.00
5/1/2025
Meta Platforms, Inc. stock logo
META
Meta Platforms
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$752.00 ➝ $664.00
5/1/2025
Meta Platforms, Inc. stock logo
META
Meta Platforms
TD Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$725.00 ➝ $700.00
5/1/2025
Meta Platforms, Inc. stock logo
META
Meta Platforms
Susquehanna
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetPositive ➝ Positive$800.00 ➝ $700.00
5/1/2025
Meta Platforms, Inc. stock logo
META
Meta Platforms
Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$675.00 ➝ $725.00
5/1/2025
Meta Platforms, Inc. stock logo
META
Meta Platforms
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$650.00 ➝ $683.00
5/1/2025
Meta Platforms, Inc. stock logo
META
Meta Platforms
Roth Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy$580.00 ➝ $620.00
5/1/2025
Meta Platforms, Inc. stock logo
META
Meta Platforms
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy$685.00 ➝ $690.00
4/30/2025
Deutsche Bank Aktiengesellschaft stock logo
DB
Deutsche Bank Aktiengesellschaft
Cfra Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeModerate Sell ➝ Hold
(Data available from 5/3/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Deutsche Bank Aktiengesellschaft stock logo
DB
Deutsche Bank Aktiengesellschaft
$30.05B1.78$5.98 per share4.48$43.15 per share0.62
Meta Platforms, Inc. stock logo
META
Meta Platforms
$170.36B8.88$26.41 per share22.61$72.08 per share8.28
Medicure Inc. stock logo
MPH
Medicure
C$21.08M0.41C$0.33 per share2.49C$1.91 per share0.43
Voyageur Pharmaceuticals Ltd. stock logo
VM
Voyageur Pharmaceuticals
N/AN/AC$0.01 per share35.00C$0.01 per shareN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Deutsche Bank Aktiengesellschaft stock logo
DB
Deutsche Bank Aktiengesellschaft
$3.64B$1.3919.278.61N/A4.66%3.90%0.22%N/A
Meta Platforms, Inc. stock logo
META
Meta Platforms
$62.36B$25.6424.9619.761.4237.91%38.17%25.31%N/A
Medicure Inc. stock logo
MPH
Medicure
-C$2.03M-C$0.19N/AN/A-9.65%-10.18%-5.63%N/A
Voyageur Pharmaceuticals Ltd. stock logo
VM
Voyageur Pharmaceuticals
-C$1.66M-C$0.01N/AN/AN/A-117.77%-30.77%N/A

Latest MPH, META, DB, and VM Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/30/2025Q1 2025
Meta Platforms, Inc. stock logo
META
Meta Platforms
$5.33$6.43+$1.10$6.43$41.45 billion$42.31 billion
4/29/2025Q1 2025 (Prepared Remarks)
Deutsche Bank Aktiengesellschaft stock logo
DB
Deutsche Bank Aktiengesellschaft
$0.85$1.04+$0.19$1.04$7.95 billion$8.97 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Deutsche Bank Aktiengesellschaft stock logo
DB
Deutsche Bank Aktiengesellschaft
$0.210.79%N/A15.18%4 Years
Meta Platforms, Inc. stock logo
META
Meta Platforms
$2.100.35%N/A8.19%N/A
Medicure Inc. stock logo
MPH
Medicure
N/A2.24%N/AN/AN/A
Voyageur Pharmaceuticals Ltd. stock logo
VM
Voyageur Pharmaceuticals
N/AN/AN/AN/AN/A

Latest MPH, META, DB, and VM Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/3/2025
Deutsche Bank Aktiengesellschaft stock logo
DB
Deutsche Bank Aktiengesellschaft
annual$0.51221.7%5/23/20255/26/20255/27/2025
2/13/2025
Meta Platforms, Inc. stock logo
META
Meta Platforms
quarterly$0.52500.29%3/14/20253/14/20253/26/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Deutsche Bank Aktiengesellschaft stock logo
DB
Deutsche Bank Aktiengesellschaft
1.45
0.74
0.78
Meta Platforms, Inc. stock logo
META
Meta Platforms
0.16
2.98
2.98
Medicure Inc. stock logo
MPH
Medicure
4.65
2.03
1.29
Voyageur Pharmaceuticals Ltd. stock logo
VM
Voyageur Pharmaceuticals
4.23
0.10
0.84

Institutional Ownership

CompanyInstitutional Ownership
Deutsche Bank Aktiengesellschaft stock logo
DB
Deutsche Bank Aktiengesellschaft
27.90%
Meta Platforms, Inc. stock logo
META
Meta Platforms
79.91%
Medicure Inc. stock logo
MPH
Medicure
23.10%
Voyageur Pharmaceuticals Ltd. stock logo
VM
Voyageur Pharmaceuticals
N/A

Insider Ownership

CompanyInsider Ownership
Deutsche Bank Aktiengesellschaft stock logo
DB
Deutsche Bank Aktiengesellschaft
N/A
Meta Platforms, Inc. stock logo
META
Meta Platforms
13.71%
Medicure Inc. stock logo
MPH
Medicure
26.68%
Voyageur Pharmaceuticals Ltd. stock logo
VM
Voyageur Pharmaceuticals
10.24%
CompanyEmployeesShares OutstandingFree FloatOptionable
Deutsche Bank Aktiengesellschaft stock logo
DB
Deutsche Bank Aktiengesellschaft
83,0001.99 billionN/AOptionable
Meta Platforms, Inc. stock logo
META
Meta Platforms
86,5002.53 billion2.19 billionOptionable
Medicure Inc. stock logo
MPH
Medicure
N/A10.44 millionN/ANot Optionable
Voyageur Pharmaceuticals Ltd. stock logo
VM
Voyageur Pharmaceuticals
N/A151.52 millionN/ANot Optionable

Recent News About These Companies

Canadian Investment Regulatory Organization Trading Halt - VM
Voyageur Pharmaceuticals Ltd (VM)
Voyageur Pharmaceuticals Ltd VM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Deutsche Bank Aktiengesellschaft stock logo

Deutsche Bank Aktiengesellschaft NYSE:DB

$26.78 +0.38 (+1.44%)
Closing price 05/2/2025 03:59 PM Eastern
Extended Trading
$26.88 +0.09 (+0.35%)
As of 05/2/2025 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Deutsche Bank Aktiengesellschaft, a stock corporation, provides corporate and investment banking, and asset management products and services to private individuals, corporate entities, and institutional clients in Germany, the United Kingdom, rest of Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. It operates through Corporate Bank, Investment Bank, Private Bank, and Asset Management segments. The Corporate Bank segment offers cash management, trade finance and lending, trust and agency, and securities services, as well as risk management solutions. The Investment Bank segment provides debt origination, merger and acquisitions, foreign exchange, and equity advisory and origination platform services. The Private Bank segment offers payment and account services, and credit and deposit products, as well as investment advice products, such as environmental, social, and governance products. This segment also provides banking, wealth management, other financial, and postal and parcel services; and supports in planning, managing and investing wealth, financing personal and business interests, and servicing institutional and corporate needs. The Asset Management segment offers investment solutions, such as alternative investments, which include real estate, infrastructure, liquid real assets, and sustainable investments; and various other services, including insurance and pension solutions, asset liability management, portfolio management solutions, and asset allocation advisory to individuals and institutions. Deutsche Bank Aktiengesellschaft was founded in 1870 and is headquartered in Frankfurt am Main, Germany.

Meta Platforms stock logo

Meta Platforms NASDAQ:META

$597.02 +24.81 (+4.34%)
Closing price 05/2/2025 04:00 PM Eastern
Extended Trading
$596.85 -0.17 (-0.03%)
As of 05/2/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Meta Platforms, Inc. engages in the development of products that enable people to connect and share with friends and family through mobile devices, personal computers, virtual reality headsets, and wearables worldwide. It operates in two segments, Family of Apps and Reality Labs. The Family of Apps segment offers Facebook, which enables people to share, discuss, discover, and connect with interests; Instagram, a community for sharing photos, videos, and private messages, as well as feed, stories, reels, video, live, and shops; Messenger, a messaging application for people to connect with friends, family, communities, and businesses across platforms and devices through text, audio, and video calls; and WhatsApp, a messaging application that is used by people and businesses to communicate and transact privately. The Reality Labs segment provides augmented and virtual reality related products comprising consumer hardware, software, and content that help people feel connected, anytime, and anywhere. The company was formerly known as Facebook, Inc. and changed its name to Meta Platforms, Inc. in October 2021. The company was incorporated in 2004 and is headquartered in Menlo Park, California

Medicure stock logo

Medicure CVE:MPH

C$0.83 -0.12 (-12.63%)
As of 04/30/2025 11:22 AM Eastern

Medicure Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction. It also offers ZYPITAMAG to treat patients with primary hyperlipidemia or mixed dyslipidemia. In addition, the company is developing Sodium Nitroprusside injection, and Generic ANDA 2 and 3 for acute cardiology; and TARDOCAL, to treat neurological indications. It offers products through retail and mail order pharmacies. The company was incorporated in 1997 and is headquartered in Winnipeg, Canada.

Voyageur Pharmaceuticals stock logo

Voyageur Pharmaceuticals CVE:VM

C$0.19 0.00 (0.00%)
As of 05/2/2025 03:59 PM Eastern

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd. and changed its name to Voyageur Pharmaceuticals Ltd. in December 2019. Voyageur Pharmaceuticals Ltd. was founded in 2017 and is headquartered in Calgary, Canada.